Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.616 EUR | -1.10% |
|
+1.89% | +156.51% |
06-20 | European Equities Traded in the US as American Depositary Receipts Retreat Friday | MT |
06-17 | European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading | MT |
Capitalization | 221M 255M 208M 189M 350M 22.06B 394M 2.46B 943M 10.11B 956M 936M 37.16B | P/E ratio 2025 * |
-2.17x | P/E ratio 2026 * | -1.88x |
---|---|---|---|---|---|
Enterprise value | 192M 221M 181M 164M 303M 19.14B 342M 2.14B 818M 8.77B 829M 811M 32.22B | EV / Sales 2025 * |
73.4x | EV / Sales 2026 * | 59.4x |
Free-Float |
98.83% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: DBV Technologies
More recommendations
More press releases
More news
1 day | -1.10% | ||
1 week | +1.89% | ||
Current month | +8.02% | ||
1 month | -2.53% | ||
3 months | +82.60% | ||
6 months | +173.90% | ||
Current year | +156.51% |
1 week | 1.57 | ![]() | 1.75 |
1 month | 1.3 | ![]() | 1.78 |
Current year | 0.62 | ![]() | 2.38 |
1 year | 0.51 | ![]() | 2.38 |
3 years | 0.51 | ![]() | 5.3 |
5 years | 0.51 | ![]() | 13.69 |
10 years | 0.51 | ![]() | 86.64 |
Manager | Title | Age | Since |
---|---|---|---|
Daniel Tassé
CEO | Chief Executive Officer | 65 | 2018-11-28 |
Director of Finance/CFO | 55 | 2023-11-05 | |
Chief Operating Officer | - | 2023-11-30 |
Director | Title | Age | Since |
---|---|---|---|
Don Soland
BRD | Director/Board Member | 66 | 2015-03-05 |
Michael Goller
BRD | Director/Board Member | 50 | 2015-10-20 |
Maïlys Ferrère
BRD | Director/Board Member | 61 | 2016-06-20 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.10% | +1.89% | +68.68% | -65.99% | 255M | ||
+1.24% | -3.92% | -33.79% | -30.06% | 55.29B | ||
+0.12% | -0.30% | -7.73% | -15.12% | 8.91B | ||
-0.64% | -2.17% | +3.83% | +19.64% | 6.51B | ||
+3.07% | -2.16% | +33.42% | +110.02% | 5.65B | ||
+2.99% | +2.88% | +20.96% | +37.83% | 5.31B | ||
-1.24% | -13.37% | +55.19% | -6.97% | 3.22B | ||
-2.06% | +0.78% | +20.45% | +19.47% | 2.02B | ||
-0.10% | -3.42% | -0.57% | +14.44% | 1.95B | ||
+1.95% | +2.15% | -18.52% | -25.85% | 1.76B | ||
Average | +0.42% | -1.68% | +14.19% | +5.74% | 9.09B | |
Weighted average by Cap. | +1.03% | -3.03% | -15.51% | -9.50% |
2025 * | 2026 * | |
---|---|---|
Net sales | 2.61M 3.01M 2.46M 2.23M 4.13M 261M 4.66M 29.12M 11.14M 119M 11.29M 11.05M 439M | 2.51M 2.9M 2.37M 2.15M 3.98M 251M 4.48M 28.01M 10.72M 115M 10.86M 10.63M 422M |
Net income | -109M -126M -103M -93.34M -173M -10.89B -195M -1.22B -466M -4.99B -472M -462M -18.34B | -113M -130M -106M -96.65M -179M -11.28B -201M -1.26B -482M -5.17B -488M -478M -18.99B |
Net Debt | -29.34M -33.82M -27.63M -25.11M -46.45M -2.93B -52.34M -327M -125M -1.34B -127M -124M -4.93B | -71.72M -82.68M -67.56M -61.38M -114M -7.16B -128M -800M -306M -3.28B -310M -304M -12.06B |
More financial data
* Estimated data
Employees
106
Sector
Pharmaceuticals
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-06-20 | 1.616 € | -1.10% | 286,814 |
25-06-19 | 1.634 € | -0.73% | 359,796 |
25-06-18 | 1.646 € | -3.40% | 569,914 |
25-06-17 | 1.704 € | +3.02% | 738,774 |
25-06-16 | 1.654 € | +4.29% | 437,512 |
Real-time Euronext Paris, June 20, 2025 at 11:35 am
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.616EUR
Average target price
1.520EUR
Spread / Average Target
-5.94%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DBV Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition